About Cure Mito Foundation
To unite the global Leigh syndrome community to accelerate patient-centered research, treatments, and cures.
Focus Areas
Leigh syndromeMitochondrial diseaseGene therapyDrug repurposingMitochondria transfer/transplantationMicrobiome researchPatient registry developmentClinical trial preparedness
Who They Fund
researchersacademic institutionsresearch teams
Funding Style
research grantsproject-based funding
About Cure Mito Foundation
Cure Mito Foundation concentrates on Leigh syndrome research, with funding and collaborations that move from gene therapy and drug repurposing to mitochondria transfer and transplantation studies. Its recent grant activity includes a $201,437 research award to Biologics and a $105,700 research initiative to University of Texas Southwestern, showing support for both project-based science and institution-linked work. The foundation also backs translational efforts tied to clinical trial readiness, alongside microbiome research and patient-registry development as part of its broader mitochondrial disease agenda. The foundation’s work is organized around targeted research programs rather than broad unrestricted support. In the recent grants list, Perlara received $13,500 for a research initiative, while UCLA received $11,409 for research, both within the same Leigh syndrome and mitochondrial-disease framework. Cure Mito Foundation’s stated purpose is to unite the global Leigh syndrome community to accelerate patient-centered research, treatments, and cures, and its grantmaking reflects that focus through partnerships with academic institutions, research teams, and specialized labs.
What Cure Mito Foundation Funds
In gene therapy, Cure Mito Foundation supported University of Texas Southwestern with a $105,700 research initiative, aligning with its emphasis on Leigh syndrome-related genes such as SURF1, ECHS1, and MT-ATP6. In translational work, Biologics received $201,437 for research, reflecting the foundation’s interest in moving projects toward practical treatment development. The foundation also funds research on alternative therapeutic approaches. Perlara received $13,500 for a research initiative, fitting the drug repurposing and preclinical screening theme in the funder’s program areas. UCLA received $11,409 for research, showing continued support for academic projects within the Leigh syndrome and mitochondrial disease portfolio. Across these awards, the foundation backs investigator-led work, academic partnerships, and projects that can advance clinical trial preparedness.
How Cure Mito Foundation Gives
Cure Mito Foundation’s active research grantmaking includes awards ranging from $34,000 to $400,000, with a median recent grant size near the lower end of that band based on the listed awards. The top recent grant was $201,437, and the foundation also made a $105,700 award, indicating a mix of mid-sized and smaller project grants. It is a Public Charity and does not fund individuals. The grant programs include both unsolicited opportunities and targeted collaborations, with some programs explicitly accepting proposals and others operating by invitation or partnership. Recent awards point to repeated project-based support across the same research theme rather than one-off community grants.
Financial Snapshot
Annual Giving
$373K
Total Assets
$1.1M
Total Revenue
$479K
Total Expenses
$502K
Geographic Reach
Regional3 states funded
About 20% of grants go to recipients in CA.
Funding intensity
LowHigh
Headquarters
Unlock Deep Analysis
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeSee Similar Funders
Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeExplore related grant guides
Want a Personalized Pitch for Cure Mito Foundation?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Free plan available
No contracts
Cancel anytime